Lanka Ventures makes strategic investment in biomedical start-up

Damith Pallwatte, Keerthi Kodithuwakku and Palitha Gamage sign and accept investment to Jendo Innovations

Lanka Ventures PLC, a prominent Sri Lankan investment firm, has announced a strategic investment in Jendo Innovations, a cutting-edge biomedical engineering start-up based in Sri Lanka. 
Jendo Innovations has pioneered a revolutionary medical device designed to advance the early diagnosis of vascular diseases and this significant investment is poised to propel its innovation into the global healthcare market. 

Jendo Innovations’ groundbreaking product, the Jendo device, has garnered widespread attention for its ability to analyse endothelial function, a critical indicator in the early stages of numerous cardiovascular diseases. 
By harnessing the power of non-invasive techniques such as Photoplethysmography (PPG) and Digital Thermal Monitoring (DTM), the Jendo device ensures a comfortable and seamless experience for patients while delivering highly accurate results.

The device’s cloud-based artificial intelligence system further amplifies its capabilities by efficiently processing and analysing data. This makes it an invaluable tool for diagnosing conditions like atherosclerosis, nephropathy, neuropathy and varicose veins, transforming the landscape of vascular health assessment.  What sets Jendo Innovations apart is its pioneering diagnostics methods for vascular assessment, which has undergone extensive clinical testing and received patents in key markets such as the United States, Japan and Sri Lanka. These patents underscore the device’s uniqueness and its immense potential to revolutionise vascular health assessment globally. 
Lanka Ventures PLC, with major shareholders including Hatton National Bank and DFCC Bank, has primarily focused its investments in the energy and health sectors. Its decision to invest in Jendo Innovations reflects the firm’s commitment to supporting groundbreaking innovations in healthcare technology.

“We are excited to be part of Jendo Innovations’ journey. Its groundbreaking technology has the potential to make a significant impact on global healthcare by enabling early diagnosis of vascular diseases. We believe in its vision and are confident that this investment will help bring its innovation to market faster,” Lanka Ventures PLC Chairman Damith Pallewatte said.
Jendo Innovations co-founder and CEO Keerthi Kodithuwakku said, “We are thrilled to have Lanka Ventures as our partner. This investment will accelerate our plans to move from the prototype stage to production. We also aim to secure regulatory approvals in Sri Lanka, Japan and the USA, bringing our groundbreaking technology to patients worldwide.”